A citation-based method for searching scientific literature

Rebecca S Cook, Kristen M Jacobsen, Anne M Wofford, Deborah DeRyckere, Jamie Stanford, Anne L Prieto, Elizabeth Redente, Melissa Sandahl, Debra M Hunter, Karen E Strunk, Douglas K Graham, H Shelton Earp. J Clin Invest 2013
Times Cited: 111







List of co-cited articles
1411 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.
Douglas K Graham, Deborah DeRyckere, Kurtis D Davies, H Shelton Earp. Nat Rev Cancer 2014
405
53

TAM receptors are pleiotropic inhibitors of the innate immune response.
Carla V Rothlin, Sourav Ghosh, Elina I Zuniga, Michael B A Oldstone, Greg Lemke. Cell 2007
702
38

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Magdalena Paolino, Axel Choidas, Stephanie Wallner, Blanka Pranjic, Iris Uribesalgo, Stefanie Loeser, Amanda M Jamieson, Wallace Y Langdon, Fumiyo Ikeda, Juan Pablo Fededa,[...]. Nature 2014
287
36

Phagocytosis and clearance of apoptotic cells is mediated by MER.
R S Scott, E J McMahon, S M Pop, E A Reap, R Caricchio, P L Cohen, H S Earp, G K Matsushima. Nature 2001
862
30

Immunobiology of the TAM receptors.
Greg Lemke, Carla V Rothlin. Nat Rev Immunol 2008
563
29

Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Wen-I Tsou, Khanh-Quynh N Nguyen, Daniel A Calarese, Scott J Garforth, Anita L Antes, Sergey V Smirnov, Steve C Almo, Raymond B Birge, Sergei V Kotenko. J Biol Chem 2014
140
29

TAM receptor signaling in immune homeostasis.
Carla V Rothlin, Eugenio A Carrera-Silva, Lidia Bosurgi, Sourav Ghosh. Annu Rev Immunol 2015
254
29

Diversification of TAM receptor tyrosine kinase function.
Anna Zagórska, Paqui G Través, Erin D Lew, Ian Dransfield, Greg Lemke. Nat Immunol 2014
252
28

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
Rachel M A Linger, Amy K Keating, H Shelton Earp, Douglas K Graham. Adv Cancer Res 2008
486
27

T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.
Eugenio A Carrera Silva, Pamela Y Chan, Leonel Joannas, Andrea E Errasti, Nicola Gagliani, Lidia Bosurgi, Maurice Jabbour, Anthony Perry, Faye Smith-Chakmakova, Daniel Mucida,[...]. Immunity 2013
117
26


Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.
R B Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, R A Brekken, X Huang, J T Hutchins,[...]. Cell Death Differ 2016
337
26

UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.
Weihe Zhang, Deborah DeRyckere, Debra Hunter, Jing Liu, Michael A Stashko, Katherine A Minson, Christopher T Cummings, Minjung Lee, Trevor G Glaros, Dianne L Newton,[...]. J Med Chem 2014
91
28


Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Heather M Seitz, Todd D Camenisch, Greg Lemke, H Shelton Earp, Glenn K Matsushima. J Immunol 2007
271
24

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.
Marka R Crittenden, Jason Baird, David Friedman, Talicia Savage, Lauren Uhde, Alejandro Alice, Benjamin Cottam, Kristina Young, Pippa Newell, Cynthia Nguyen,[...]. Oncotarget 2016
61
39

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.
Jamie C Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B Vaught, Meghan M Morrison, Jiyeon Lim, Michelle Williams, Dana M Brantley-Sieders,[...]. J Clin Invest 2014
91
25

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Canan Kasikara, Sushil Kumar, Stanley Kimani, Wen-I Tsou, Ke Geng, Viralkumar Davra, Ganapathy Sriram, Connor Devoe, Khanh-Quynh N Nguyen, Anita Antes,[...]. Mol Cancer Res 2017
74
31

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Erin D Lew, Jennifer Oh, Patrick G Burrola, Irit Lax, Anna Zagórska, Paqui G Través, Joseph Schlessinger, Greg Lemke. Elife 2014
162
22

Tyro-3 family receptors are essential regulators of mammalian spermatogenesis.
Q Lu, M Gore, Q Zhang, T Camenisch, S Boast, F Casagranda, C Lai, M K Skinner, R Klein, G K Matsushima,[...]. Nature 1999
372
21

The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.
T N Stitt, G Conn, M Gore, C Lai, J Bruno, C Radziejewski, K Mattsson, J Fisher, D R Gies, P F Jones. Cell 1995
587
21

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Jennifer Schlegel, Maria J Sambade, Susan Sather, Stergios J Moschos, Aik-Choon Tan, Amanda Winges, Deborah DeRyckere, Craig C Carson, Dimitri G Trembath, John J Tentler,[...]. J Clin Invest 2013
104
20

Cloning and mRNA expression analysis of a novel human protooncogene, c-mer.
D K Graham, T L Dawson, D L Mullaney, H R Snodgrass, H S Earp. Cell Growth Differ 1994
259
20

Biology of the TAM receptors.
Greg Lemke. Cold Spring Harb Perspect Biol 2013
331
20

MERTK as negative regulator of human T cell activation.
Raquel Cabezón, E Antonio Carrera-Silva, Georgina Flórez-Grau, Andrea E Errasti, Elisabeth Calderón-Gómez, Juan José Lozano, Carolina España, Elena Ricart, Julián Panés, Carla Vanina Rothlin,[...]. J Leukoc Biol 2015
60
31

Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.
Gaetano Zizzo, Brendan A Hilliard, Marc Monestier, Philip L Cohen. J Immunol 2012
350
18

Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.
Sonja Loges, Thomas Schmidt, Marc Tjwa, Katie van Geyte, Dirk Lievens, Esther Lutgens, Davy Vanhoutte, Delphine Borgel, Stephane Plaisance, Marc Hoylaerts,[...]. Blood 2010
120
18


Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.
Philip L Cohen, Roberto Caricchio, Valsamma Abraham, Todd D Camenisch, J Charles Jennette, Robert A S Roubey, H Shelton Earp, Glenn Matsushima, Elizabeth A Reap. J Exp Med 2002
481
18

UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.
Deborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, Amanda A Hill, Jeffrey W Tyner, Kristen M Jacobsen, Lauren S Page, Gregory G Kirkpatrick, Fatma Eryildiz, Stephanie A Montgomery,[...]. Clin Cancer Res 2017
38
47


R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
Sacha J Holland, Alison Pan, Christian Franci, Yuanming Hu, Betty Chang, Weiqun Li, Matt Duan, Allan Torneros, Jiaxin Yu, Thilo J Heckrodt,[...]. Cancer Res 2010
353
17

axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.
J P O'Bryan, R A Frye, P C Cogswell, A Neubauer, B Kitch, C Prokop, R Espinosa, M M Le Beau, H S Earp, E T Liu. Mol Cell Biol 1991
623
17

Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.
Lidia Bosurgi, Jochem H Bernink, Victor Delgado Cuevas, Nicola Gagliani, Leonel Joannas, Edward T Schmid, Carmen J Booth, Sourav Ghosh, Carla V Rothlin. Proc Natl Acad Sci U S A 2013
94
18


MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
Alisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, Madeline G Huey, Rebecca E Parker, Lauren S Page, Amanda A Hill, Xiaodong Wang, Stephen V Frye, H Shelton Earp,[...]. JCI Insight 2018
38
44

Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
Yi Zhou, Mingjian Fei, Gu Zhang, Wei-Ching Liang, WeiYu Lin, Yan Wu, Robert Piskol, John Ridgway, Erin McNamara, Haochu Huang,[...]. Immunity 2020
118
17

A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.
Susan Sather, Karla D Kenyon, Jerry B Lefkowitz, Xiayuan Liang, Brian C Varnum, Peter M Henson, Douglas K Graham. Blood 2007
220
16

Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
Khanh-Quynh N Nguyen, Wen-I Tsou, Daniel A Calarese, Stanley G Kimani, Sukhwinder Singh, Shelly Hsieh, Yongzhang Liu, Bin Lu, Yi Wu, Scott J Garforth,[...]. J Biol Chem 2014
59
27

Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells.
Pradip Sen, Mark A Wallet, Zuoan Yi, Yingsu Huang, Michael Henderson, Clayton E Mathews, H Shelton Earp, Glenn Matsushima, Albert S Baldwin, Roland M Tisch. Blood 2007
152
15

TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis.
Jonathan H M van der Meer, Tom van der Poll, Cornelis van 't Veer. Blood 2014
173
15

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
R M A Linger, R A Cohen, C T Cummings, S Sather, J Migdall-Wilson, D H G Middleton, X Lu, A E Barón, W A Franklin, D T Merrick,[...]. Oncogene 2013
140
15

Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
Eric Ubil, Laura Caskey, Alisha Holtzhausen, Debra Hunter, Charlotte Story, H Shelton Earp. J Clin Invest 2018
78
19

UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo.
Sandra Christoph, Deborah Deryckere, Jennifer Schlegel, J Kimble Frazer, Lance A Batchelor, Alesia Y Trakhimets, Susan Sather, Debra M Hunter, Christopher T Cummings, Jing Liu,[...]. Mol Cancer Ther 2013
42
33

The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity.
Edward M Behrens, Paul Gadue, Shun-you Gong, Stacey Garrett, Paul L Stein, Philip L Cohen. Eur J Immunol 2003
86
16

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
14

Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
Amanda Kirane, Kathleen F Ludwig, Noah Sorrelle, Gry Haaland, Tone Sandal, Renate Ranaweera, Jason E Toombs, Miao Wang, Sean P Dineen, David Micklem,[...]. Cancer Res 2015
94
14

Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.
Christopher T Cummings, Weihe Zhang, Kurtis D Davies, Gregory D Kirkpatrick, Dehui Zhang, Deborah DeRyckere, Xiaodong Wang, Stephen V Frye, H Shelton Earp, Douglas K Graham. Mol Cancer Ther 2015
38
36

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.
Canan Kasikara, Viralkumar Davra, David Calianese, Ke Geng, Thomas E Spires, Michael Quigley, Michael Wichroski, Ganapathy Sriram, Lucia Suarez-Lopez, Michael B Yaffe,[...]. Cancer Res 2019
50
28

TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages.
Federica Alciato, Pier Paolo Sainaghi, Daniele Sola, Luigi Castello, Gian Carlo Avanzi. J Leukoc Biol 2010
137
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.